China
Africa
Explore chapters and articles related to this topic
Effect of Infra-Low Frequency (ILF) Neurofeedback on the Functional State of the Brain in Healthy and Depressed Individuals
Published in Hanno W. Kirk, Restoring the Brain, 2020
Vera A. Grin-Yatsenko, Juri Kropotov
The second pilot study tracked changes observed within the conventional EEG spectrum – another area of investigation that has been relatively neglected to date in the evaluation of ILF NF. This study describes changes of symptoms and EEG parameters in three depressed but unmedicated individuals after 20 sessions of ILF NF training. The clinical symptoms in each subject were rated pre- and post-treatment with three Depression Rating Scales: Montgomery-Asberg Depression Rating Scale (MADRS); Hamilton Depression Rating Scale (HAMD); and Beck Depression Inventory (BDI). The QEEG parameters were assessed in Eyes-open and Eyes-closed resting states, as well as during a visual GO/NOGO challenge.
Electrode placement
Published in Alan Weiss, The Electroconvulsive Therapy Workbook, 2018
The final results of the PRIDE study have now been published (Kellner et al., 2016). Of the 240 patients who entered phase one of the study, there were 174 who successfully completed. Overall, 61.7% (148/240) of all patients met remission criteria, 10% (24/240) did not remit and 28.3% (68/240) dropped out, with 70% (169/240) meeting response criteria. Among those who remitted, the mean decrease in the 24-item Hamilton Depression Rating Scale was 24.7 points with a mean final score of 7.3 and an average change from baseline of 79%. The average number of treatments to remission was 7.3. This data highlights the efficacy of ultrabrief RUL ECT combined with venlafaxine as a highly effective treatment option for depressed geriatric patients with excellent safety and tolerability.
Development of palliative medicine in the United Kingdom and Ireland
Published in Eduardo Bruera, Irene Higginson, Charles F von Gunten, Tatsuya Morita, Textbook of Palliative Medicine and Supportive Care, 2015
126 Olden M, Rosenfeld B, Pessin H, and Breitbart W. Measuring depression at the end of life: Is the Hamilton depression rating scale a valid instrument? Assessment 2009;16:43-54. 127 Zigmond A and Snaith RP. The hospital anxiety depression scale. Acta Psychiatric Scand 1983;67:367-370.
Association between obsession, compulsion, depression and insight in obsessive-compulsive disorder: a meta-analysis
Published in Nordic Journal of Psychiatry, 2022
Jun Gan, Jing He, Hong Fu, Xiongzhao Zhu
A total of 20 published studies met the inclusion criteria (Table 1). The combined sample size of these studies was 2887 (OCD-PI group: n = 663; OCD-GI group: n = 2224). The mean age of participants was 32.11 ± 11.39 years. Scores of YBOCS were used to report the severity of obsessive-compulsive symptoms in the current study. Of these, 19 studies reported the total score of YBOCS, while 15 studies reported the scores of obsessive subscale of YBOCS (YBOCS-O) and compulsive subscale of YBOCS (YBOCS-C), and one study just reported scores of YBOCS-O and YBOCS-C. A total of 15 studies reported the severity of depression via Zung’s Self-rating Depression Scale (SDS) for 1 study, Montgomery Asberg Depression Rating Scale (MADRS) for 1 study, Inventory of Depressive Symptomatology -Self Report (IDS-SR) for one study, Beck Depression Inventory (BDI) for four studies, and Hamilton Depression Rating Scale (HDRS) for seven studies. Study characteristics are presented in Table 1. There were five longitudinal studies that reporting the statistics of the correlation of insight and treatment outcomes for O-C or depressive symptoms.
Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials
Published in Expert Review of Neurotherapeutics, 2021
Dongyun Su, Yuqing Zhang, Anzi Wang, Di Shao, Fenghua Xu, Meng Dong, Libo Zhao, Yang Hu, Haiyan Luo
Prespecified secondary analyses included the following: (i) disability, as measured by functional disability scores (e.g. the Barthel Index [BI] and Functional Independence Measure [FIM]) at the end of treatment; (ii) neurological function, as measured by the mean scores from stroke severity scales (e.g., the Scandinavian neurological stroke scale [SSS], National Institutes of Health Stroke Score [NIHSS] and the Hemispheric Stroke Scale [HSS]) at the end of treatment; (iii) continuous depression scores (e.g., Hamilton depression rating scale [HAMD] and the Montgomery-Åsberg Depression Rating Scale [MADRS] at the end of treatment) and (iv) adverse events including drowsiness, epileptic seizures, gastrointestinal side effects, hepatic enzyme disorders, hyponatremia, insomnia, palpitation, and psychiatric disorders.
The Relationship Between Maladaptive Personality and Social Role Impairment in Depressed Older Adults in Primary Care
Published in Clinical Gerontologist, 2021
Aliza Romirowsky, Richard Zweig, Lauren Glick Baker, Jo Anne Sirey
Information was obtained by interviews with the participants. Data gathered included date of birth, age, gender, race, marital status, educational and occupational history, current living situation, medical history, and current medications. Disease burden was measured using the Chronic Disease Score (CDS; Clark, Von Korff, Saunders, Baluch, & Simon, 1995), which was calculated using a weighted algorithm to determine disease severity based on the patient’s prescription medications. Depression was measured using the Hamilton Depression Rating Scale (HAM-D; Hamilton, 1960), a clinician administered scale developed to assess the severity of depression symptoms. The HAM-D has been used extensively in samples of older adults in primary care (e.g. Gallo et al., 2007; Sirey et al., 2010).